22nd Century Group, Inc. is a biotechnology company dedicated to the development of innovative technologies to improve the health and well-being of individuals. They focus on modifying the nicotine content in tobacco products to help reduce addiction to harmful substances. Their flagship brand, VLN®, provides the lowest nicotine cigarettes on the market, aimed at assisting smokers in transitioning away from traditional high-nicotine options. The company emphasizes consumer choice and control, positioning itself at the forefront of harm reduction in the tobacco industry.
Website: | tryvln.com |
Social Link: | https://xxiicentury.com/ |